In July 2013, Bonus BioGroup successfully inaugurated a first-of-its-kind human bone graft manufacturing facility. The facility is an integral addition to Bonus BioGroup's 1,000sqm laboratories and offices complex at Matam Advanced Technology Park in Haifa, Israel. The facility consists of three divisions:
- Manufacturing Facility for the production human bone grafts, to be utilized in the company's clinical trials. The manufacturing facility includes a set of clean rooms and quality control and assurance units. The facility was established in compliance with the European Good Manufacturing Practice (GMP) instructions and meets all advanced therapy regulations in regard to the production of clinical-grade cellular products suitable for human therapy. The facility is GMP and ISO 9001- certified, and enables the company full control over the entire process of bone graft production.
- R&D Center committed to ongoing pursuit of performance excellence and innovation.
- Headquarters for Bonus BioGroup's management team, which will also supervise the company's R&D activities in the United States.